Use of the CRISPR/Cas9-based epigenetic gene activation system In Vivo: A new potential therapeutic modality

Research output: Contribution to journalArticle

1 Citation (Scopus)
Original languageEnglish (US)
Pages (from-to)1191-1193
Number of pages3
JournalHepatology
Volume68
Issue number3
DOIs
StatePublished - Sep 1 2018

Fingerprint

Clustered Regularly Interspaced Short Palindromic Repeats
Epigenomics
Transcriptional Activation
Therapeutics

ASJC Scopus subject areas

  • Hepatology

Cite this

Use of the CRISPR/Cas9-based epigenetic gene activation system In Vivo : A new potential therapeutic modality. / Ibrahim, Samar C; Robertson, Keith D.

In: Hepatology, Vol. 68, No. 3, 01.09.2018, p. 1191-1193.

Research output: Contribution to journalArticle

@article{06bf824cb8394672bd8a3fd036510a95,
title = "Use of the CRISPR/Cas9-based epigenetic gene activation system In Vivo: A new potential therapeutic modality",
author = "Ibrahim, {Samar C} and Robertson, {Keith D}",
year = "2018",
month = "9",
day = "1",
doi = "10.1002/hep.29860",
language = "English (US)",
volume = "68",
pages = "1191--1193",
journal = "Hepatology",
issn = "0270-9139",
publisher = "John Wiley and Sons Ltd",
number = "3",

}

TY - JOUR

T1 - Use of the CRISPR/Cas9-based epigenetic gene activation system In Vivo

T2 - A new potential therapeutic modality

AU - Ibrahim, Samar C

AU - Robertson, Keith D

PY - 2018/9/1

Y1 - 2018/9/1

UR - http://www.scopus.com/inward/record.url?scp=85047525907&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85047525907&partnerID=8YFLogxK

U2 - 10.1002/hep.29860

DO - 10.1002/hep.29860

M3 - Article

C2 - 29489018

AN - SCOPUS:85047525907

VL - 68

SP - 1191

EP - 1193

JO - Hepatology

JF - Hepatology

SN - 0270-9139

IS - 3

ER -